NKTR News

Pomerantz LLP Reports Filing of Class Action Litigation Against Nektar Therapeutics – NKTR

Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm

NKTR Shareholder Alert: Nektar Therapeutics Securities Class Action Lawsuit – Investors Should Contact The Gross Law Firm

NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Class Action Filing Announced by Pomerantz LLP Against Nektar Therapeutics – NKTR

Pomerantz Law Firm Announces The Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR

Nektar Therapeutics Class Action Reminder – Robbins LLP Encourages NKTR Investors to Contact the Firm for Information About Their Rights

Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

NKTR IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors with Losses in Excess of $100K to Secure Counsel Before Important May 5 Deadline in Securities Class Action - NKTR